ArticleDiabetology international2021

Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM).

Kazuyuki Tobe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.